Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study

Human Vaccines and Immunotherapeutics

Volumn 13, Issue 2, 2017, Pages 399-404

  Alicino, Cristiano ^a   Trucchi, Cecilia ^a   Paganino, Chiara ^a   Barberis, Ilaria ^a   Boccalini, Sara ^b   Martinelli, Domenico ^c   Pellizzari, Barbara ^d   Bechini, Angela ^b   Orsi, Andrea ^a   Bonanni, Paolo ^b   Prato, Rosa ^c   Iannazzo, Stefania ^e   Icardi, Giancarlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d Regional Center for Disease Prevention and Control   (Italy)

^e MINISTRY OF HEALTH   (Italy)

Author keywords

epidemiology; herpes zoster; incidence; Italy; post herpetic neuralgia

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEURALGIA; NEUROLOGICAL COMPLICATION; POST HERPETIC NEURALGIA; SKIN DISEASE; VIREMIA; COMPLICATION; INCIDENCE; NEURALGIA, POSTHERPETIC; SEX DIFFERENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; SEX FACTORS;

EID: 85010638245     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2017.1264834     Document Type: Article

References (22)

1. Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines 2010; 9(3 Suppl):21-6; PMID:20192714; http://dx.doi.org/10.1586/erv.10.30
2. Cohen JI. Clinical practice:Herpes zoster. N Engl J Med 2013; 369(3):255-63; PMID:23863052; http://dx.doi.org/10.1056/NEJMcp1302674
3. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster:towards a global perspective. BMJ Open 2014; 4:e004833; PMID:24916088; http://dx.doi.org/10.1136/bmjopen-2014-004833
4. Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 1993; 4:222-30; http://dx.doi.org/10.1097/00013542-199310000-00006
5. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32:1481-6; PMID:11317250; http://dx.doi.org/10.1086/320169
6. Schmader K, Gnann JW, Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008; 197:S207-15; PMID:18419399; http://dx.doi.org/10.1086/522152
7. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37; PMID:20565946; http://dx.doi.org/10.1186/1741-7015-8-37
8. Whitley RJ, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following Herpes Zoster. J Infect Dis 1998; 178:S71-5; PMID:9852979; http://dx.doi.org/10.1086/514274
9. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62:1545-51; PMID:15136679; http://dx.doi.org/10.1212/01.WNL.0000123261.00004.29
10. Gabutti G, Valente N, Sulcaj N, Stefanati A. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine. J Prev Med Hyg 2014; 55:130-6; PMID:26137786
11. Volpi A. Severe complications of herpes zoster. Herpes 2007; 14(Suppl 2):35-9.
12. Di Luzio Paparatti U, Arpinelli F, Visona G. Herpes zoster and its complications in Italy:an observational survey. J Infect 1999; 38:116-119; PMID:10342652; http://dx.doi.org/10.1016/S0163-4453(99)90079-8
13. Di Legami V, Gianino MM, Atti MCD, Massari M, Migliardi A, Tomba GS, Zotti C, Zoster Study Group. Epidemiology and costs of herpes zoster:background data to estimate the impact of vaccination. Vaccine 2007; 25:7598-7604; PMID:17889410; http://dx.doi.org/10.1016/j.vaccine.2007.07.049
14. Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy:a retrospective, population-based study. BMC Infect Dis 2010; 10:230; PMID:20682044; http://dx.doi.org/10.1186/1471-2334-10-230
15. Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, et al. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study:The SHEZ study. J Epidemiol 2015; 25:617-25; PMID:26399445; http://dx.doi.org/10.2188/jea.JE20140210
16. Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect 2004; 132:1-5; PMID:14979582; http://dx.doi.org/10.1017/S0950268803001523
17. Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis 2015; 15:502; PMID:26546419; http://dx.doi.org/10.1186/s12879-015-1262-8
18. Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, et al. Predictors of postherpetic neuralgia in patients with herpes zoster:a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int J Infect Dis 2015; 34:126-31; PMID:25841633; http://dx.doi.org/10.1016/j.ijid.2015.03.022
19. Tran KD, Falcone MM, Choi DS, Goldhardt R, Karp CL, Davis JL, Galor A. Epidemiology of Herpes Zoster Ophthalmicus:Recurrence and chronicity. Ophthalmology 2016; 123:1469-75; PMID:27067924; http://dx.doi.org/10.1016/j.ophtha.2016.03.005
20. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011; 86:88-93; PMID:21220354; http://dx.doi.org/10.4065/mcp.2010.0618
21. Paganino C, Alicino C, Trucchi C, Albanese E, Sticchi L, Icardi G. Herpes Zoster:the rationale for the introduction of vaccination in Italy. J Prev Med Hyg 2015; 56:E33-6; PMID:26789830
22. Ansaldi F, Trucchi C, Alicino C, Paganino C, Orsi A, Icardi G. Real-world effectiveness and safety of a live-attenuated herpes zoster vaccine:a comprehensive review. Adv Ther 2016; 33:1094-104; PMID:27262452; http://dx.doi.org/10.1007/s12325-016-0355-0